Allergy Therapeutics plc (LON:AGY – Get Free Report) shares crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 4.59 ($0.06) and traded as low as GBX 4.50 ($0.06). Allergy Therapeutics shares last traded at GBX 5.42 ($0.07), with a volume of 493,909 shares changing hands.
Allergy Therapeutics Stock Performance
The firm’s 50-day moving average price is GBX 4.75 and its 200-day moving average price is GBX 4.59. The company has a debt-to-equity ratio of 37.22, a current ratio of 1.40 and a quick ratio of 1.48. The stock has a market cap of £258.53 million, a P/E ratio of -90.33, a PEG ratio of -30.70 and a beta of 1.40.
Allergy Therapeutics Company Profile
Allergy Therapeutics plc, a commercial biotechnology company, engages in the research and development of allergy treatments. The company sells injectable and sublingual allergen-specific immunotherapies; and offers prescription for the treatment of pollen-related allergies particularly to grasses, weeds, and trees, as well as diagnostics.
Read More
- Five stocks we like better than Allergy Therapeutics
- Insider Buying Explained: What Investors Need to Know
- Rocket Lab is the Right Stock for the Right Time
- How is Compound Interest Calculated?
- SoundHound AI Will Advance By Triple Digits in 2025: Here’s Why
- Best Aerospace Stocks Investing
- Celsius Holdings: Big Drop, Big Opportunity? Analysts Say Yes
Receive News & Ratings for Allergy Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allergy Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
